Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Inspire Medical Systems (INSP) Accumulated Depreciation & Amortization (2017 - 2025)

Inspire Medical Systems' Accumulated Depreciation & Amortization history spans 9 years, with the latest figure at $14.0 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 113.74% to $14.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.0 million, a 113.74% increase, with the full-year FY2025 number at $14.0 million, up 113.74% from a year prior.
  • Accumulated Depreciation & Amortization hit $14.0 million in Q4 2025 for Inspire Medical Systems, up from $3.7 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for INSP hit a ceiling of $14.0 million in Q4 2025 and a floor of $234000.0 in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $2.5 million across 5 years, with a median of $1.3 million in 2022.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: crashed 38.46% in 2023 and later soared 361.29% in 2025.
  • Tracing INSP's Accumulated Depreciation & Amortization over 5 years: stood at $1.2 million in 2021, then surged by 54.83% to $1.9 million in 2022, then soared by 53.18% to $2.8 million in 2023, then skyrocketed by 130.15% to $6.6 million in 2024, then skyrocketed by 113.74% to $14.0 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for INSP at $14.0 million in Q4 2025, $3.7 million in Q3 2025, and $6.5 million in Q2 2025.